First-in-class cancer drug at TGA

By Megan Brodie 3 years ago | In Companies, Products, Regulatory
  • 3 years ago

24 May 2021 A first-in-class drug targeting a rare mutation that causes cancer of the…

This is subscriber-only content. Please login to continue reading.